Literature DB >> 3337372

Comparison of ketanserin and sodium nitroprusside in patients with severe ARDS.

P Radermacher1, Y Huet, F Pluskwa, R Herigault, H Mal, B Teisseire, F Lemaire.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3337372     DOI： 10.1097/00000542-198801000-00030

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  11 in total

Review 1.  Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension.

Authors:  P Egermayer; G I Town; A J Peacock
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

2.  Alveolar ventilation and pulmonary blood flow: the V(A)/Q concept.

Authors:  Enrico Calzia; Peter Radermacher
Journal:  Intensive Care Med       Date:  2003-07-10       Impact factor: 17.440

Review 3.  Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

Review 4.  The pulmonary circulation in acute lung injury: a review of some recent advances.

Authors:  M Leeman
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

Review 5.  The use, and misuse, of exogenous endothelial-derived vasodilators in acute respiratory failure.

Authors:  A T Dinh-Xuan; F Brunet; J F Dhainaut
Journal:  Intensive Care Med       Date:  1997-11       Impact factor: 17.440

6.  Prostacyclin and right ventricular function in patients with pulmonary hypertension associated with ARDS.

Authors:  P Radermacher; B Santak; H J Wüst; J Tarnow; K J Falke
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

Review 7.  Inhaled vasodilator therapy in acute lung injury: first, do NO harm?

Authors:  S J Brett; T W Evans
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

8.  Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome.

Authors:  H Gerlach; D Pappert; K Lewandowski; R Rossaint; K J Falke
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 9.  Recognition and management of pulmonary hypertension.

Authors:  J C Wanstall; T K Jeffery
Journal:  Drugs       Date:  1998-12       Impact factor: 9.546

10.  Effects of inhaled nitric oxide on right ventricular function in severe acute respiratory distress syndrome.

Authors:  R Rossaint; K Slama; W Steudel; H Gerlach; D Pappert; S Veit; K Falke
Journal:  Intensive Care Med       Date:  1995-03       Impact factor: 17.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.